A New Model of Care for Familial Hypercholesterolaemia: What is the Role of Cardiology?

Heart Lung and Circulation

Volumn 21, Issue 9, 2012, Pages 543-550

  Watts, Gerald F ^a   Sullivan, David R ^b   van Bockxmeer, Frank M ^c   Poplawski, Nicola ^d   Hamilton Craig, Ian ^e   Clifton, Peter M ^f   O'Brien, Richard C ^g   Bishop, Warrick ^h   George, Peter M ⁱ   Semsarian, Christopher ^b   Tonkin, Andrew ^j  

^a UNIVERSITY OF WESTERN AUSTRALIA   (Australia)

^b ROYAL PRINCE ALFRED HOSPITAL   (Australia)

^c UNIVERSITY OF WESTERN AUSTRALIA   (Australia)

^d WOMEN S AND CHILDREN S HOSPITAL   (Australia)

^e GOLD COAST UNIVERSITY HOSPITAL   (Australia)

^f BAKER IDI HEART AND DIABETES INSTITUTE   (Australia)

^g UNIVERSITY OF MELBOURNE   (Australia)

^h Calvary Cardiac Centre   (Australia)

ⁱ UNIVERSITY OF OTAGO   (New Zealand)

^j MONASH UNIVERSITY   (Australia)

more..

Author keywords

Familial hypercholesterolaemia; Model of care; Role of cardiology

Indexed keywords

CHOLESTEROL; LOW DENSITY LIPOPROTEIN CHOLESTEROL;

APHERESIS; AUSTRALIA; CARDIOLOGIST; CARDIOLOGY; CHOLESTEROL BLOOD LEVEL; CLINICAL ASSESSMENT; FAMILIAL HYPERCHOLESTEROLEMIA; FAMILY HISTORY; GENETIC ANALYSIS; HEALTH SERVICE; HUMAN; ISCHEMIC HEART DISEASE; LIPID METABOLISM; NEW ZEALAND; PATIENT CARE; PHENOTYPE; PHYSICAL EXAMINATION; PRACTICE GUIDELINE; PRIORITY JOURNAL; PROGNOSIS; REVIEW; RISK ASSESSMENT;

AUSTRALIA; CARDIOLOGY; CHOLESTEROL; CHOLIC ACIDS; CORONARY DISEASE; HUMANS; NEW ZEALAND; PRACTICE GUIDELINES AS TOPIC; STEROID METABOLISM, INBORN ERRORS;

EID: 84864312879     PISSN: 14439506     EISSN: 14442892     Source Type: Journal    
DOI: 10.1016/j.hlc.2012.04.010     Document Type: Review

References (38)

1. Austin M.A., Hutter C.M., Zimmern R.L., Humphries S.E. Genetic causes of monogenic heterozygous familial hypercholesterolaemia: a HuGE prevalence review. Am J Epidemiol 2004, 160(5):407-420.
2. Austin M.A., Hutter C.M., Zimmern R.L., Humphries S.E. Familial hypercholesterolemia and coronary heart disease: a HuGE association review. Am J Epidemiol 2004, 160(5):421-429.
3. Soutar A.K., Naoumova R.P. Mechanisms of disease: genetic causes of familial hypercholesterolemia. Nat Clin Pract Cardiovasc Med 2007, 4(4):214-225.
4. Marks D., Thorogood M., Neil H.A.W., Humphries S.E. A review on the diagnosis, natural history, and treatment of familial hypercholesterolaemia. Atherosclerosis 2003, 168:1-14.
5. Versmissen J., Oosterveer D.M., Yazdanpanah M., Defesche J.C., Basart D.C.G., Liem A.H., et al. Efficacy of statins in familial hypercholesterolaemia: a long term cohort study. Br Med J 2008, 337:a2423.
6. Neil A., Cooper J., Betteridge J., Capps N., McDowell I., Durrington P., et al. Reductions in all-cause, cancer, and coronary mortality in statin-treated patients with heterozygous familial hypercholesterolaemia: a prospective registry study. Eur Heart J 2008, 29(21):2625-2633.
7. Raal F.J., Pilcher G.J., Panz V.R., van Deventer H.E., Brice B.C., Blom D.J., et al. Reduction in mortality in subjects with homozygous familial hypercholesterolemia associated with advances in lipid-lowering therapy. Circulation 2011, 124:2202-2207.
8. Neil H.A.W., Hammond T., Huxley R., Matthews D.R., Humphries S.E. Extent of underdiagnosis of familial hypercholesterolaemia in routine practice: prospective registry study. Br Med J 2000, 321(7254):148.
9. Pijlman A.H., Huijgen R., Verhagen S.N., Imholz B.P.M., Liem A.H., Kastelein J.J.P., et al. Evaluation of cholesterol lowering treatment of patients with familial hypercholesterolemia: a large cross-sectional study in the Netherlands. Atherosclerosis 2010, 209(1):189-194.
10. Bates T.R., Burnett J.R., van Bockxmeer F.M., Hamilton S., Arnolda L., Watts G.F. Detection of familial hypercholesterolaemia: a major treatment gap in preventative cardiology. Heart Lung Circ 2008, 17(5):411-413.
11. National Institute for Health and Clinical Excellence, The National Collaborating Centre for Primary Care. NICE clinical guideline 71: identification and management of familial hypercholesterolaemia. Available from: 2008 [2011]. http://www.nice.org.uk/nicemedia/pdf/CG071NICEGuideline.pdf.
12. Civeira F. Guidelines for the diagnosis and management of heterozygous familial hypercholesterolaemia. Atherosclerosis 2004, 173:55-68.
13. Goldberg A.C., Hopkins P.N., Toth P.P., Ballantyne C.M., Rader D.J., Robinson J.G., et al. Familial hypercholesterolemia: screening, diagnosis and management of pediatric and adult patients: clinical guidance from the National Lipid Association Expert Panel on Familial Hypercholesterolemia. J Clin Lipidol 2011, 5(3):133-140.
14. Descamps O.S., Tenoutasse S., Stephenne X., Gies I., Beauloye V., Lebrethon M.C., et al. Management of familial hypercholesterolemia in children and young adults: consensus paper developed by a panel of lipidologists, cardiologists, paediatricians, nutritionists, gastroenterologists, general practitioners and a patient organization. Atherosclerosis 2011, 218(2):272-280.
15. Watts G.F., Sullivan D.R., Poplawski N., van Bockxmeer F., Hamilton-Craig I., Clifton P.M., et al. Familial hypercholesterolaemia: a model of care for Australasia. Atherosclerosis 2011, 12(Suppl.):221-263.
16. Thompson G.R. HEART-UK LDL Apheresis Working Group. Recommendations for the use of LDL apheresis. Atherosclerosis 2008, 198(2):247-255.
17. Humphries S. Guidelines for the identification and management of patients with familial hypercholesterolaemia (FH): are we coming to a consensus? Atherosclerosis 2011, 12(Suppl.):217-220.
18. Williams R.R., Hunt S.C., Schumacher M.C., Hegele R.A., Leppert M.F., Ludwig E.H., et al. Diagnosing heterozygous familial hypercholesterolemia using new practical criteria validated by molecular genetics. Am J Cardiol 1993, 72(2):171-176.
19. World Health Organization. Familial hypercholesterolaemia. Report of a second WHO consultation. Geneva: World Health Organization; 1999.
20. Reiner Ž., Catapano A.L., De Backer G., Graham I., Taskinen M.-R., et al. ESC/EAS guidelines for the management of dyslipidaemias. Eur Heart J 2011, 32(14):1769-1818.
21. Humphries S.E., Norbury G., Leigh S., Hadfield S.G., Nair D. What is the clinical utility of DNA testing in patients with familial hypercholesterolaemia?. Curr Opin Lipidol 2008, 19(4):362-368.
22. Burton H, Alberg C, Stewart A. Heart to heart: inherited cardiovascular conditions services. A needs assessment and service review. PHG Foundation. Available from: 2009. http://www.phgfoundation.org/reports/4986/.
23. Greenland P., Alpert J.S., Beller G.A., Benjamin E.J., Budoff M.J., Fayad Z.A., et al. 2010 ACCF/AHA guideline for assessment of cardiovascular risk in asymptomatic adults: a report of the American College of Cardiology Foundation/American Heart Association Task Force on Practice Guidelines. Circulation 2010, 122(25):2748-2764.
24. Preiss D., Sattar N. Pharmacotherapy: statins and new-onset diabetes - the important questions. Nat Rev Cardiol 2012, 9(4):190-192.
25. Robinson J.G., Goldberg A.C. Treatment of adults with familial hypercholesterolemia and evidence for treatment: Recommendations from the National Lipid Association Expert Panel on Familial Hypercholesterolemia. J Clin Lipidol 2011, 5(3):S18-S29.
26. Thorogood M., Seed M., De Mott K. Guideline Development Group. Management of fertility in women with familial hypercholesterolaemia: summary of NICE guidance. Br J Obstet Gynaecol 2009, 116(4):478-479.
27. Weintraub W.S., Daniels S.R., Burke L.E., Franklin B.A., Goff D.C., Hayman L.L., et al. Value of primordial and primary prevention for cardiovascular disease: a policy statement from the American Heart Association. Circulation 2011, 124(8):967-990.
28. Bairey Merz C.N., Mensah G.A., Fuster V., Greenland P., Thompson P.D. Task force #5-the role of cardiovascular specialists as leaders in prevention: from training to champion. J Am Coll Cardiol 2002, 40(4):641-649.
29. Block R., Pearson T. Organizing services for cardiovascular prevention. Curr Treat Options Cardiovasc Med 2007, 9(4):278-286.
30. Ingles J., Semsarian C. Sudden cardiac death in the young: a clinical genetic approach. Intern Med J 2007, 37(1):32-37.
31. Ingles J., Zodgekar P.R., Yeates L., Macciocca I., Semsarian C., Fatkin D. Guidelines for genetic testing of inherited cardiac disorders. Heart Lung Circ 2011, 20(11):681-687.
32. Ingles J., McGaughran J., Vohra J., Weintraub R.G., Davis A., Atherton J., et al. Establishment of an Australian national genetic heart disease registry. Heart Lung Circ 2008, 17(6):463-467.
33. Lentzner B., Connolly D., Phoon C. Do paediatric cardiologists discuss cardiovascular risk factors with patients and their families?. Cardiol Young 2003, 13(6):551.
34. Christie D., Viner R. Chronic illness and transition: time for action. Adolesc Med State Art Rev 2009, 20(3):981-987. xi.
35. Bairey Merz C.N., Alberts M.J., Balady G.J., Ballantyne C.M., Berra K., Black H.R., et al. ACCF/AHA/ACP 2009 competence and training statement: a curriculum on prevention of cardiovascular disease. J Am Coll Cardiol 2009, 54(14):1336-1363.
36. Fisk N.M., Wesselingh S.L., Beilby J.J., Glasgow N.J., Puddey I.B., Robinson B.G., et al. Academic health science centres in Australia: let's get competitive. Med J Aust 2011, 194(2):59-60.
37. Pedersen KMV, Humphries SE, Roughton M, Besford JS. The national audit of the management of familial hypercholesterolaemia 2010: full report. Clinical Standards Department, Royal College of Physicians. Available from: December 2010. http://www.rcplondon.ac.uk/node/2584.
38. Aarden E., Van Hoyweghen I., Horstman K. The paradox of public health genomics: definition and diagnosis of familial hypercholesterolaemia in three European countries. Scand J Public Health 2011, 39(6):634-639.